← ResourcesPublications
DIASURV · JEADV
Comparison of an AI-based prognostic assay with gene expression profiling in early-stage melanoma
Céline Bossard, Yahia Salhi, Amir Khammari, Maud Brousseau, Yannick Le Corre, Sanae Salhi, Gaëlle Quereux, Jérôme J. Chetritt
11 FEB 2026
AI-Based Prognostic Assessment Shows Promising Results in Early-Stage Melanoma A recent study published in the Journal of the European Academy of Dermatology and Venereology (JEADV) presents a comparative evaluation of an artificial intelligence (AI)-based prognostic assay, DiaSurv® Melanoma, and a gene expression profiling (GEP) test in early-stage melanoma.
Excerpt. Read the full abstract at the source below.
